Human DDX60L knockout A549 cell line
Be the first to review this product! Submit a review
|
(0 Publication)
DDX60L KO cell line available to order. KO validated by. Free of charge wild type control provided. Knockout achieved by using CRISPR/Cas9, 1 bp deletion in exon 14 and 4 bp insertion in exon 14.
View Alternative Names
DDX6L_HUMAN, DEAD (Asp Glu Ala Asp) box polypeptide 60 like, DEAD box protein 60-like, DKFZp781D1175, FLJ13468, FLJ31033, FLJ39050, Probable ATP-dependent RNA helicase DDX60-like
- Sanger seq
Unknown
Sanger Sequencing - Human DDX60L knockout A549 cell line (AB266944)
Allele-1 : 1 bp deletion in exon14
- Sanger seq
Unknown
Sanger Sequencing - Human DDX60L knockout A549 cell line (AB266944)
Allele-2 : 4 bp insertion in exon 14.
Product details
Recommended control: Human wild-type A549 cell line (ab255450). Please note a wild-type cell line is not automatically included with a knockout cell line order, if required please add recommended wild-type cell line at no additional cost using the code WILDTYPE-TMTK1.
We will provide viable cells that proliferate on revival.
This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.
What's included?
Properties and storage information
Gene name
Gene editing type
Gene editing method
Knockout validation
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Handling procedures
Initial handling guidelines
Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.
1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.
2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.
3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.
4. Incubate the culture at 37°C incubator with 5% CO2. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.
5. Once confluent passage into an appropriate flask at a density of 2x104 cells/cm2. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.
Subculture guidelines
- All seeding densities should be based on cell counts gained by established methods.
- A guide seeding density of 2x104 cells/cm2 is recommended.
- Cells should be passaged when they have achieved 80-90% confluence.
- Do not allow the cell density to exceed 7x104 cells/cm2.
Culture medium
F-12K + 10% FBS
Cryopreservation medium
Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The functions of DDX60L include sensing viral RNA and activating downstream immune responses. It associates with other similar proteins to form a complex that initiates sensing pathways for RNA viruses. This engagement leads to the activation of innate immune responses which are essential for detecting and responding to infections. DDX60L is part of signaling complexes contributing to the regulation and modulation of immune pathways.
Pathways
DDX60L plays a pivotal role in the RIG-I-like receptor (RLR) signaling pathway. This pathway detects viral RNAs and initiates antiviral responses through interferon production. DDX60L interacts with proteins like RIG-I (retinoic acid-inducible gene I) to regulate the type I interferon signaling pathway enhancing the body's ability to fight viral infections. The protein contributes to maintaining cellular homeostasis under immune stress conditions.
Quality control
STR analysis
CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX
Cell culture
Biosafety level
EU: 1 US: 1
Adherent/suspension
Adherent
Gender
Male
Target data
Complementary Products
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com